Ryman Healthcare Group Ltd. buy tbackenh
Start price
27.05.19
/
50%
€6.82
Target price
08.07.19
€7.75
Performance (%)
6.01%
End price
08.07.19
€7.16
Summary
This prediction ended on 08.07.19 with a price of €7.16. The BUY prediction by tbackenh finished with a performance of 6.01%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ryman Healthcare Group Ltd. | -0.908% | -0.908% | -36.842% | -67.589% |
| iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
| iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
| iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
| iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
According to tbackenh what are the pros and cons of Ryman Healthcare Group Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
Some uniques
Known brand
Top 10 in its market
Future proof or reliable business model
Cons
Comments by tbackenh for this prediction
In the thread Ryman Healthcare Group Ltd. diskutieren
Ryman Healthcare
Als Seniorenheimbetreiber hat sich Ryman zum Ziel gesetzt Missstände in der Pflegebranche auszumerzen. Ihr Grundsatz ist, es muss ‚gut genug für Mutti‘ sein. Aber auch auf der finanziellen Seite ist Ryman vielversprechend. Das Unternehmen will alle fünf Jahre den Gewinn verdoppeln, also rund 15% pro Jahr erwirtschaften. Außerdem wird gerade eine Expansion nach Australien durchgeführt.
(Stop Loss Kurs erreicht)
Stopped prediction by tbackenh for Ryman Healthcare Group Ltd.
Ryman Healthcare Group Ltd.
Start price
Target price
Perf. (%)
€7.98
13.07.21
13.07.21
€10.00
13.07.22
13.07.22
-31.03%
13.07.22
13.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
